公开(公告)号：AU2003202719A1

公开(公告)日：2003-07-30

申请号：AU2003202719

申请日：2003-01-15

Applicant: REDDYS LAB LTD DR

Inventor： NATESAN SELVAKUMAR ,  TREHAN SANJAY ,  IQBAL JAVED ,  MAGADI SITARAM KUMAR ,  MAMIDI NAGA VENKATA SRINIVASA ,  RAMANUJAM RAJAGOPALAN ,  DAS JAGATTARAN

IPC: A61K31/4192 ,  A61K31/454 ,  A61K31/496 ,  A61K31/5355 ,  A61K31/5377 ,  A61K31/541 ,  A61K31/655 ,  A61P31/00 ,  A61P31/04 ,  C07D249/06 ,  C07D295/12 ,  C07D295/135 ,  C07D401/06 ,  C07D401/10 ,  C07D401/12 ,  C07D403/12 ,  C07D405/10 ,  C07D413/02 ,  C07D413/14 ,  C07D417/02 ,  C07D417/10 ,  C07D417/14

公开(公告)号：CA2463686A1

公开(公告)日：2003-04-24

申请号：CA2463686

申请日：2002-10-15

Applicant: REDDYS LAB LTD DR

Inventor： CHAKRABARTI RANJAN ,  BHUNIYA DEBNATH ,  DAS SAIBAL KUMAR ,  MADHAVAN GURRAM RANGA ,  IQBAL JAVED

IPC: A61K9/08 ,  A61K9/10 ,  A61K9/14 ,  A61K9/20 ,  A61K9/48 ,  A61K31/538 ,  A61K31/5415 ,  A61P1/04 ,  A61P1/14 ,  A61P1/18 ,  A61P3/04 ,  A61P3/06 ,  A61P3/10 ,  A61P9/10 ,  A61P9/12 ,  A61P13/12 ,  A61P15/00 ,  A61P17/06 ,  A61P19/10 ,  A61P21/04 ,  A61P25/28 ,  A61P29/00 ,  A61P35/00 ,  A61P43/00 ,  C07B61/00 ,  C07C227/04 ,  C07C227/18 ,  C07C229/34 ,  C07C229/42 ,  C07D265/36 ,  C07D279/16

Abstract: The present invention relates to novel antidiabetic, hypolipidemic, antiobesity and hypocholesterolemic compounds of formula (I) their derivatives, their analogs, their tautomeric forms, their stereoisomers, the ir polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them, to a process for preparing such compounds. More particularly, the present invention relates to novel alkyl carboxylic acids of the general, their derivatives, their analogs, their tautomeric forms, their stereoisomer s, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them, to a process for preparing such compounds. The present invention also relates to processes for the preparation of the compounds of formula (I), novel intermediates, processes for their preparation, their use in the preparation of the above said compounds and their use as antidiabetic, hypolipidemic, antiobesity and hypocholesterolemi c compounds.